GlaxoSmithKline related Press Releases
GSK Upbeat on Solid Results - Interviews with CEO and CFO
LONDON, February 7, 2012 /PRNewswire/ -- In an online video interview with MerchantCantos, GlaxoSmithKline CEO Sir Andrew Witty talks about the pharmaceutical group's special dividend, solid results Read more...
Prosensa Raises €23 Million in New Equity Financing Led by New Enterprise Associates
LEIDEN, Netherlands--(BUSINESS WIRE)-- Prosensa, the Dutch biopharmaceutical company focusing on RNA-modulating therapeutics for rare diseases with high unmet needs, announced today that it has Read more...
Impax Pharmaceuticals Submits New Drug Application for IPX066 in Parkinson's Disease
Impax Pharmaceuticals Submits New Drug Application for IPX066 in Parkinson's Disease HAYWARD, Calif.--(BUSINESS WIRE)--Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc. Read more...
GSK receives initial data from the first completed phase lll study of albiglutide in type 2 diabetes
GSK receives initial data from the first completed phase lll study of albiglutide in type 2 diabetes Issued: Wednesday 16 November 2011, London UK Head-to-head study primary end point did not meet Read more...
XenoPort to Present at the 23rd Annual Piper Jaffray Health Care Conference
SANTA CLARA, Calif.--(BUSINESS WIRE)-- XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the 23rd Annual Piper Jaffray Health Read more...
ChemoCentryx Reports Clinical Efficacy for CCX354, a Novel CCR1 Inhibitor in a Phase II Study in Patients with Rheumatoid Arthri
Results Presented in Late-Breaker Oral Presentation at the Annual Meeting of the American College of Rheumatology (ACR)MOUNTAIN VIEW, Calif., Nov. 8, 2011 /PRNewswire/ -- ChemoCentryx, Inc., today Read more...
Prosensa Named Most Innovative European Biotech SME
Company wins prestigious EuropaBio Award LEIDEN, Netherlands--(BUSINESS WIRE)-- Prosensa, the Dutch biopharmaceutical company focusing on rare diseases with a high unmet medical need, has won Read more...
Seattle Genetics to Present at Two Upcoming Investor Conferences
BOTHELL, Wash.--(BUSINESS WIRE)-- Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that management will present at the following upcoming investor conferences. Credit Suisse Healthcare Read more...
Anacor Pharmaceuticals Announces Third Quarter 2011 Financial Results Conference Call and Webcast
PALO ALTO, Calif.--(BUSINESS WIRE)-- Anacor Pharmaceuticals (NASDAQ:ANAC) will release its financial results for the third quarter ended September 30, 2011, on Thursday November 10, 2011 at Read more...
XenoPort to Present at the Credit Suisse Healthcare Conference
SANTA CLARA, Calif.--(BUSINESS WIRE)-- XenoPort, Inc. (Nasdaq:XNPT) announced today that it will provide access via the World Wide Web to its presentation at the 2011 Credit Suisse Healthcare Read more...
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
